CMM Treatment ApS: Financial statements 2020
CVR: 38553038
Source: annual report 2020, Danish Business Authority
01/07/2019 – 30/06/2020
CMM Treatment ApS (CVR 38553038) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -7,500 and a net result of DKK -5,850 compared with DKK -5,850 the year before. Equity in the 2020 report amounted to DKK 18,691. The solvency ratio was 78.9%.
- Gross Profit
- DKK -7,500
- Profit/Loss
- DKK -5,850
- Equity
- DKK 18,691
- Total Assets
- DKK 23,691
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -8 t. | -6 t. | 19 t. | 0 |
| 2019 | - | -8 t. | -6 t. | 25 t. | - |
Official annual report
How creditworthy is CMM Treatment ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout CMM Treatment ApS
CMM Treatment ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2017. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named CMM Treatment IVS. The management consists of Thomas Frilund Jacobsen. The company's owners include Marina Jacobsen, Martin Vetling and Claus Vetling. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -8,500 and a net result of DKK -8,500 compared with DKK -8,250 the year before. Equity in the 2025 report amounted to DKK -5,720.